Cargando...
Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer: EGFR and beyond
Commonly observed aberrations in epidermal growth factor receptor (EGFR) signaling have led to the development of EGFR-targeted therapies for various cancers, including non–small cell lung cancer (NSCLC). EGFR mutations and overexpression have further been shown to modulate sensitivity to these EGFR...
Gardado en:
| Publicado en: | Chin J Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4593375/ https://ncbi.nlm.nih.gov/pubmed/25962919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-015-0007-9 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|